ADD CONDITION

items per page

Ink Scribd Tattoo Numbing

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Lidocaine Hydrochloride 4 g/100 g
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2025
Label revision date
July 31, 2025
Active ingredient
Lidocaine Hydrochloride 4 g/100 g
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2025
Label revision date
July 31, 2025
Manufacturer
Prodigy Media Inc
Registration number
M017
NDC root
70171-0009

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Ink Scribd Numbing is a medication designed to provide temporary relief from pain and itching caused by sunburns, minor cuts, insect bites, and various skin irritations. It can help soothe discomfort and promote a sense of relief when you experience these common skin issues.

Uses

You can use this medication for the temporary relief of pain and itching caused by sunburns, minor cuts, insect bites, and various skin irritations. It helps soothe discomfort and provides a sense of relief when your skin is feeling irritated or damaged.

Rest assured, there are no known teratogenic effects (which means it doesn't cause birth defects) associated with this medication, making it a safer option for those concerned about such risks.

Dosage and Administration

If you are an adult or a child aged 2 years and older, you can apply this medication to the affected area up to 3 to 4 times a day. Make sure to follow this guideline to ensure the best results.

However, if your child is under 2 years old, it’s important not to use this medication without first consulting a physician (doctor). Always prioritize safety and seek professional advice when it comes to younger children.

What to Avoid

It's important to be aware of specific instructions regarding the use of this product. If you accidentally swallow it, seek medical help or contact a Poison Control Center immediately. This is crucial for your safety.

There are no listed contraindications, controlled substance classifications, or concerns about abuse, misuse, or dependence (a condition where your body becomes reliant on a substance). However, always use this product as directed to ensure your well-being.

Side Effects

It's important to be aware of some key warnings when using this product. It is for external use only, so you should avoid contact with your eyes. If your condition worsens or symptoms persist for more than 7 days, or if symptoms clear up and then return within a few days, you should stop using the product and consult a doctor. Additionally, do not apply it in large amounts, especially on raw or blistered areas, and do not exceed the recommended daily dosage unless directed by a healthcare professional.

You should also avoid using this product on wounds or damaged skin to prevent any potential complications.

Warnings and Precautions

This product is for external use only, so please avoid getting it in your eyes. It's important to use it as directed and not to apply it in large amounts, especially on raw or blistered skin. If your condition worsens or does not improve after 7 days, or if your symptoms go away and then come back within a few days, stop using the product and consult your doctor.

If you accidentally swallow the product, seek emergency medical help or contact a Poison Control Center immediately. Always prioritize your safety and well-being when using any medication.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to err on the side of caution when it comes to your health. Remember, if you have any concerns or questions about your medication, don’t hesitate to reach out to your healthcare provider for guidance.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to be cautious with the use of lidocaine HCl cream, as its safety during pregnancy has not been established. You should consult your physician before using this cream, as potential risks to your fetus are not clearly defined.

While there are no specific dosage modifications for pregnant individuals, it is essential to discuss your situation with a healthcare provider to ensure safe use. Only use this cream if it is clearly needed and after consulting with your doctor.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding the use of this product while nursing. Additionally, there is no information available about whether this product is excreted in breast milk or any potential risks to your infant. Always consult with your healthcare provider if you have any concerns or questions about medications while breastfeeding.

Pediatric Use

When using this medication for children aged 2 years and older, you can apply it to the affected area up to 3 to 4 times a day. However, if your child is under 2 years old, it’s important not to use this medication without first consulting a physician (a medical doctor).

Always remember to keep the medication out of reach of children to ensure their safety. If you have any questions or concerns about its use, don’t hesitate to reach out to your healthcare provider for guidance.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider before starting the medication. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.

Always consult your healthcare provider for personalized advice and to ensure that any medications you take are safe and appropriate for your kidney health. They can help you understand how your condition may affect your treatment and what steps to take for your safety.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (liver issues).

Always consult your healthcare provider for personalized advice and to discuss any concerns regarding your liver health and how it may relate to your treatment. They can help ensure that you receive the safest and most effective care.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking, even if there are no specific drug interactions or laboratory test interactions noted for your treatment. This ensures that your healthcare team can monitor your health effectively and make informed decisions about your care.

Always feel free to ask questions and share all the medications and supplements you are using. This helps to avoid any potential issues and ensures that you receive the best possible treatment tailored to your needs.

Storage and Handling

To ensure the best performance of your product, store it at room temperature. This helps maintain its effectiveness and safety. Before using it, always check that the seal is intact; do not use the product if the seal is broken, as this could compromise its safety and effectiveness.

By following these simple storage and handling guidelines, you can help ensure that the product remains safe for use.

Additional Information

You should apply this medication topically to the affected area, using it no more than 3 to 4 times a day if you are an adult or a child aged 2 years and older. If your child is under 2 years old, do not use this medication without consulting a physician first. There are no additional details available regarding laboratory tests, abuse potential, or patient counseling.

FAQ

What is Ink Scribd Numbing used for?

Ink Scribd Numbing is used for the temporary relief of pain and itching associated with sunburns, minor cuts, insect bites, and skin irritations.

How should I apply Ink Scribd Numbing?

Adults and children 2 years of age and older should apply it to the affected area not more than 3 to 4 times daily. Children under 2 years of age should not use it and should consult a physician.

Are there any warnings for using Ink Scribd Numbing?

Yes, it is for external use only, and you should avoid contact with eyes. Stop use and consult a doctor if the condition worsens or symptoms persist for more than 7 days.

What should I do if Ink Scribd Numbing is swallowed?

If the product is swallowed, get medical help or contact a Poison Control Center right away.

Is Ink Scribd Numbing safe to use during pregnancy?

The safety of Ink Scribd Numbing during pregnancy has not been established. Consult a physician before use if you are pregnant or planning to become pregnant.

Can I use Ink Scribd Numbing on wounds or damaged skin?

No, you should not use Ink Scribd Numbing on wounds or damaged skin.

How should I store Ink Scribd Numbing?

Store Ink Scribd Numbing at room temperature and do not use it if the seal is broken.

Packaging Info

Below are the non-prescription pack sizes of Ink Scribd Tattoo Numbing (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Ink Scribd Tattoo Numbing.
Details

Drug Information (PDF)

This file contains official product information for Ink Scribd Tattoo Numbing, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the temporary relief of pain and itching associated with sunburns, minor cuts, insect bites, and skin irritations.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. It is important to ensure that the application is limited to the specified frequency to avoid potential adverse effects.

For children under 2 years of age, the product should not be used without consulting a physician. Healthcare professionals are advised to assess the necessity and safety of treatment in this age group before proceeding with any application.

Contraindications

There are no specific contraindications listed for this product. However, it is imperative to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes. In the event that the condition worsens or symptoms persist for more than 7 days, the patient should discontinue use and consult a healthcare professional. Additionally, if symptoms resolve and then recur within a few days, medical advice should be sought. The product should not be applied in large quantities, especially over raw surfaces or blistered areas, and the recommended daily dosage should not be exceeded unless directed by a physician. It is also contraindicated for use on wounds or damaged skin.

In cases where the product is ingested, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Patients are advised to stop using the product and consult their doctor if the condition worsens or if symptoms persist beyond 7 days. Furthermore, if symptoms improve and then reappear within a short timeframe, it is essential to seek medical advice.

Side Effects

Patients should be aware that the product is for external use only and must avoid contact with the eyes. It is crucial to stop use and consult a doctor if the condition worsens or if symptoms persist for more than 7 days. Additionally, if symptoms clear up and then recur within a few days, medical advice should be sought.

Patients are advised against using the product in large quantities, particularly over raw surfaces or blistered areas, and should not exceed the recommended daily dosage unless directed by a healthcare professional. Furthermore, the product should not be applied to wounds or damaged skin.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Ink Scribd Tattoo Numbing (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Ink Scribd Tattoo Numbing.
Details

Pediatric Use

Pediatric patients aged 2 years and older may apply the medication to the affected area no more than 3 to 4 times daily. For children under 2 years of age, the use of this medication is not recommended, and consultation with a physician is advised. It is important to keep the medication out of reach of children to ensure safety.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The safety of lidocaine HCl cream during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a physician prior to use. Potential risks to the fetus are not clearly defined; therefore, caution is advised when considering the use of this medication in pregnant individuals.

No specific dosage modifications for pregnant individuals are provided; it is essential to consult a physician for guidance on appropriate use. Lidocaine HCl cream should only be used if clearly needed and after a thorough discussion with a healthcare provider regarding the potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding the use of this product in lactating mothers. Additionally, there is no information available concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that if the product is swallowed, it is crucial to seek medical help immediately or contact a Poison Control Center. This information is vital for ensuring patient safety and prompt intervention in case of accidental ingestion.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity and effectiveness. Additionally, users must ensure that the seal remains intact; the product should not be used if the seal is broken, as this may compromise its safety and efficacy. Proper handling and storage conditions are crucial for optimal product performance.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of 3 to 4 times daily for adults and children aged 2 years and older. For children under 2 years of age, it is advised to consult a physician before use. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Ink Scribd Tattoo Numbing, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Ink Scribd Tattoo Numbing, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.